230 related articles for article (PubMed ID: 18980468)
21. Gender Differences in Dose of Erythropoietin to Maintain Hemoglobin Target in Hemodialysis Patients.
Coronado Daza JA; Cuchi GU
Indian J Nephrol; 2019; 29(3):160-165. PubMed ID: 31142961
[TBL] [Abstract][Full Text] [Related]
22. Erythrocytosis in hepatocellular carcinoma portends poor prognosis by respiratory dysfunction secondary to mitochondrial DNA mutations.
Ke S; Chen S; Dong Z; Hong CS; Zhang Q; Tang L; Yang P; Zhai J; Yan H; Shen F; Zhuang Z; Wen W; Wang H
Hepatology; 2017 Jan; 65(1):134-151. PubMed ID: 27774607
[TBL] [Abstract][Full Text] [Related]
23. Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution.
Luo B; Wang J; Liu Z; Shen Z; Shi R; Liu YQ; Liu Y; Jiang M; Wu Y; Zhang Z
Nat Commun; 2016 Jul; 7():12177. PubMed ID: 27397585
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis.
Lin KH; Ho YH; Chiang JC; Li MW; Lin SH; Chen WM; Chiang CL; Lin YN; Yang YJ; Chen CN; Lu J; Huang CJ; Tigyi G; Yao CL; Lee H
Sci Rep; 2016 May; 6():27050. PubMed ID: 27244685
[TBL] [Abstract][Full Text] [Related]
25. Early versus delayed erythropoietin for the anaemia of end-stage kidney disease.
Coronado Daza J; Martí-Carvajal AJ; Ariza García A; Rodelo Ceballos J; Yomayusa González N; Páez-Canro C; Loza Munárriz C; Urrútia G
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011122. PubMed ID: 26671531
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin Stimulates Tumor Growth via EphB4.
Pradeep S; Huang J; Mora EM; Nick AM; Cho MS; Wu SY; Noh K; Pecot CV; Rupaimoole R; Stein MA; Brock S; Wen Y; Xiong C; Gharpure K; Hansen JM; Nagaraja AS; Previs RA; Vivas-Mejia P; Han HD; Hu W; Mangala LS; Zand B; Stagg LJ; Ladbury JE; Ozpolat B; Alpay SN; Nishimura M; Stone RL; Matsuo K; Armaiz-Peña GN; Dalton HJ; Danes C; Goodman B; Rodriguez-Aguayo C; Kruger C; Schneider A; Haghpeykar S; Jaladurgam P; Hung MC; Coleman RL; Liu J; Li C; Urbauer D; Lopez-Berestein G; Jackson DB; Sood AK
Cancer Cell; 2015 Nov; 28(5):610-622. PubMed ID: 26481148
[TBL] [Abstract][Full Text] [Related]
27. Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis.
Yang Z; Sun B; Zhao X; Shao B; An J; Gu Q; Wang Y; Dong X; Zhang Y; Qiu Z
Int J Clin Exp Pathol; 2015; 8(4):4033-43. PubMed ID: 26097591
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological treatments for fatigue associated with palliative care.
Mücke M; ; Cuhls H; Peuckmann-Post V; Minton O; Stone P; Radbruch L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD006788. PubMed ID: 26026155
[TBL] [Abstract][Full Text] [Related]
29. Oncolytic Poxviruses.
Chan WM; McFadden G
Annu Rev Virol; 2014 Sep; 1(1):119-141. PubMed ID: 25839047
[TBL] [Abstract][Full Text] [Related]
30. Erythropoiesis-stimulating agents in the management of cancer patients with anemia: a meta-analysis.
Li X; Yan Z; Kong D; Zou W; Wang J; Sun D; Jiang Y; Zheng C
Chin J Cancer Res; 2014 Jun; 26(3):268-76. PubMed ID: 25035653
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin-derived nonerythropoietic peptide ameliorates experimental autoimmune neuritis by inflammation suppression and tissue protection.
Liu Y; Luo B; Han F; Li X; Xiong J; Jiang M; Yang X; Wu Y; Zhang Z
PLoS One; 2014; 9(3):e90942. PubMed ID: 24603865
[TBL] [Abstract][Full Text] [Related]
32. Erythropoietin-stimulating agents and clinical outcomes in metastatic breast cancer patients with chemotherapy-induced anemia: a closed debate?
Kelada O; Marignol L
Tumour Biol; 2014 Jun; 35(6):5095-100. PubMed ID: 24554413
[TBL] [Abstract][Full Text] [Related]
33. Fighting insomnia and battling lethargy: the yin and yang of palliative care.
Davis MP; Goforth H
Curr Oncol Rep; 2014 Apr; 16(4):377. PubMed ID: 24535303
[TBL] [Abstract][Full Text] [Related]
34. Vaccinia virus-mediated expression of human erythropoietin in tumors enhances virotherapy and alleviates cancer-related anemia in mice.
Nguyen DH; Chen NG; Zhang Q; Le HT; Aguilar RJ; Yu YA; Cappello J; Szalay AA
Mol Ther; 2013 Nov; 21(11):2054-62. PubMed ID: 23765443
[TBL] [Abstract][Full Text] [Related]
35. Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.
Martí-Carvajal AJ; Agreda-Pérez LH; Solà I; Simancas-Racines D
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD000332. PubMed ID: 23450527
[TBL] [Abstract][Full Text] [Related]
36. Risk management of biosimilars in oncology: each medicine is a work in progress.
Vulto AG; Crow SA
Target Oncol; 2012 Mar; 7 Suppl 1(Suppl 1):S43-9. PubMed ID: 22274817
[TBL] [Abstract][Full Text] [Related]
37. Today's challenges in pharmacovigilance: what can we learn from epoetins?
Ebbers HC; Mantel-Teeuwisse AK; Moors EH; Schellekens H; Leufkens HG
Drug Saf; 2011 Apr; 34(4):273-87. PubMed ID: 21417500
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of epoetin-beta 30,000 IU/week in correcting anaemia in patients with gastrointestinal tumours subjected to concomitant chemoradiotherapy.
Gómez A; Salgado M; Valladares-Ayerbes M; Jorge M; Carballo A; Candamio S; Izquierdo P; Peleteiro P; López R
Clin Transl Oncol; 2010 Dec; 12(12):843-8. PubMed ID: 21156416
[TBL] [Abstract][Full Text] [Related]
39. Hematology: ESAs to treat anemia--balancing the risks and benefits.
Glaspy J
Nat Rev Clin Oncol; 2009 Sep; 6(9):500-2. PubMed ID: 19707239
[No Abstract] [Full Text] [Related]
40. Erythropoietin in cancer patients.
Glaspy JA
Annu Rev Med; 2009; 60():181-92. PubMed ID: 18980468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
